
Global Oncology Injection Drug Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Oncology Injection Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oncology Injection Drug include AdvaCare, Allos Therapeutics, Alza, Celgene, CordenPharma, Debiopharm, Ferring Pharmaceuticals, Genzyme and Merrimack, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oncology Injection Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Oncology Injection Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oncology Injection Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Injection Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oncology Injection Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oncology Injection Drug sales, projected growth trends, production technology, application and end-user industry.
Oncology Injection Drug Segment by Company
AdvaCare
Allos Therapeutics
Alza
Celgene
CordenPharma
Debiopharm
Ferring Pharmaceuticals
Genzyme
Merrimack
Millennium Pharmaceuticals
Pharmascience
Praecis Pharmaceuticals
S.G. Biopharm
Taj Oncology
Eli Lilly
Oncology Injection Drug Segment by Type
Central Nervous System
Circulatory/Musculoskeletal System
Organs
Other
Oncology Injection Drug Segment by Application
Myeloma
Lymphoma
Prostate Cancer
Other
Oncology Injection Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Injection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology Injection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Injection Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oncology Injection Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Injection Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Oncology Injection Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Oncology Injection Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oncology Injection Drug include AdvaCare, Allos Therapeutics, Alza, Celgene, CordenPharma, Debiopharm, Ferring Pharmaceuticals, Genzyme and Merrimack, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oncology Injection Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Oncology Injection Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oncology Injection Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Injection Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oncology Injection Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oncology Injection Drug sales, projected growth trends, production technology, application and end-user industry.
Oncology Injection Drug Segment by Company
AdvaCare
Allos Therapeutics
Alza
Celgene
CordenPharma
Debiopharm
Ferring Pharmaceuticals
Genzyme
Merrimack
Millennium Pharmaceuticals
Pharmascience
Praecis Pharmaceuticals
S.G. Biopharm
Taj Oncology
Eli Lilly
Oncology Injection Drug Segment by Type
Central Nervous System
Circulatory/Musculoskeletal System
Organs
Other
Oncology Injection Drug Segment by Application
Myeloma
Lymphoma
Prostate Cancer
Other
Oncology Injection Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Injection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology Injection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Injection Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oncology Injection Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Injection Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
198 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Oncology Injection Drug Market by Type
- 1.2.1 Global Oncology Injection Drug Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Central Nervous System
- 1.2.3 Circulatory/Musculoskeletal System
- 1.2.4 Organs
- 1.2.5 Other
- 1.3 Oncology Injection Drug Market by Application
- 1.3.1 Global Oncology Injection Drug Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Myeloma
- 1.3.3 Lymphoma
- 1.3.4 Prostate Cancer
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Oncology Injection Drug Market Dynamics
- 2.1 Oncology Injection Drug Industry Trends
- 2.2 Oncology Injection Drug Industry Drivers
- 2.3 Oncology Injection Drug Industry Opportunities and Challenges
- 2.4 Oncology Injection Drug Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Oncology Injection Drug Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global Oncology Injection Drug Revenue by Region
- 3.2.1 Global Oncology Injection Drug Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Oncology Injection Drug Revenue by Region (2020-2025)
- 3.2.3 Global Oncology Injection Drug Revenue by Region (2026-2031)
- 3.2.4 Global Oncology Injection Drug Revenue Market Share by Region (2020-2031)
- 3.3 Global Oncology Injection Drug Sales Estimates and Forecasts 2020-2031
- 3.4 Global Oncology Injection Drug Sales by Region
- 3.4.1 Global Oncology Injection Drug Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global Oncology Injection Drug Sales by Region (2020-2025)
- 3.4.3 Global Oncology Injection Drug Sales by Region (2026-2031)
- 3.4.4 Global Oncology Injection Drug Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oncology Injection Drug Revenue by Manufacturers
- 4.1.1 Global Oncology Injection Drug Revenue by Manufacturers (2020-2025)
- 4.1.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global Oncology Injection Drug Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Oncology Injection Drug Sales by Manufacturers
- 4.2.1 Global Oncology Injection Drug Sales by Manufacturers (2020-2025)
- 4.2.2 Global Oncology Injection Drug Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global Oncology Injection Drug Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global Oncology Injection Drug Sales Price by Manufacturers (2020-2025)
- 4.4 Global Oncology Injection Drug Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global Oncology Injection Drug Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oncology Injection Drug Manufacturers, Product Type & Application
- 4.7 Global Oncology Injection Drug Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oncology Injection Drug Market CR5 and HHI
- 4.8.2 2024 Oncology Injection Drug Tier 1, Tier 2, and Tier 3
- 5 Oncology Injection Drug Market by Type
- 5.1 Global Oncology Injection Drug Revenue by Type
- 5.1.1 Global Oncology Injection Drug Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global Oncology Injection Drug Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global Oncology Injection Drug Revenue Market Share by Type (2020-2031)
- 5.2 Global Oncology Injection Drug Sales by Type
- 5.2.1 Global Oncology Injection Drug Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global Oncology Injection Drug Sales by Type (2020-2031) & (K Units)
- 5.2.3 Global Oncology Injection Drug Sales Market Share by Type (2020-2031)
- 5.3 Global Oncology Injection Drug Price by Type
- 6 Oncology Injection Drug Market by Application
- 6.1 Global Oncology Injection Drug Revenue by Application
- 6.1.1 Global Oncology Injection Drug Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global Oncology Injection Drug Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global Oncology Injection Drug Revenue Market Share by Application (2020-2031)
- 6.2 Global Oncology Injection Drug Sales by Application
- 6.2.1 Global Oncology Injection Drug Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global Oncology Injection Drug Sales by Application (2020-2031) & (K Units)
- 6.2.3 Global Oncology Injection Drug Sales Market Share by Application (2020-2031)
- 6.3 Global Oncology Injection Drug Price by Application
- 7 Company Profiles
- 7.1 AdvaCare
- 7.1.1 AdvaCare Comapny Information
- 7.1.2 AdvaCare Business Overview
- 7.1.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 AdvaCare Oncology Injection Drug Product Portfolio
- 7.1.5 AdvaCare Recent Developments
- 7.2 Allos Therapeutics
- 7.2.1 Allos Therapeutics Comapny Information
- 7.2.2 Allos Therapeutics Business Overview
- 7.2.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
- 7.2.5 Allos Therapeutics Recent Developments
- 7.3 Alza
- 7.3.1 Alza Comapny Information
- 7.3.2 Alza Business Overview
- 7.3.3 Alza Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Alza Oncology Injection Drug Product Portfolio
- 7.3.5 Alza Recent Developments
- 7.4 Celgene
- 7.4.1 Celgene Comapny Information
- 7.4.2 Celgene Business Overview
- 7.4.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Celgene Oncology Injection Drug Product Portfolio
- 7.4.5 Celgene Recent Developments
- 7.5 CordenPharma
- 7.5.1 CordenPharma Comapny Information
- 7.5.2 CordenPharma Business Overview
- 7.5.3 CordenPharma Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 CordenPharma Oncology Injection Drug Product Portfolio
- 7.5.5 CordenPharma Recent Developments
- 7.6 Debiopharm
- 7.6.1 Debiopharm Comapny Information
- 7.6.2 Debiopharm Business Overview
- 7.6.3 Debiopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Debiopharm Oncology Injection Drug Product Portfolio
- 7.6.5 Debiopharm Recent Developments
- 7.7 Ferring Pharmaceuticals
- 7.7.1 Ferring Pharmaceuticals Comapny Information
- 7.7.2 Ferring Pharmaceuticals Business Overview
- 7.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
- 7.7.5 Ferring Pharmaceuticals Recent Developments
- 7.8 Genzyme
- 7.8.1 Genzyme Comapny Information
- 7.8.2 Genzyme Business Overview
- 7.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Genzyme Oncology Injection Drug Product Portfolio
- 7.8.5 Genzyme Recent Developments
- 7.9 Merrimack
- 7.9.1 Merrimack Comapny Information
- 7.9.2 Merrimack Business Overview
- 7.9.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Merrimack Oncology Injection Drug Product Portfolio
- 7.9.5 Merrimack Recent Developments
- 7.10 Millennium Pharmaceuticals
- 7.10.1 Millennium Pharmaceuticals Comapny Information
- 7.10.2 Millennium Pharmaceuticals Business Overview
- 7.10.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
- 7.10.5 Millennium Pharmaceuticals Recent Developments
- 7.11 Pharmascience
- 7.11.1 Pharmascience Comapny Information
- 7.11.2 Pharmascience Business Overview
- 7.11.3 Pharmascience Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Pharmascience Oncology Injection Drug Product Portfolio
- 7.11.5 Pharmascience Recent Developments
- 7.12 Praecis Pharmaceuticals
- 7.12.1 Praecis Pharmaceuticals Comapny Information
- 7.12.2 Praecis Pharmaceuticals Business Overview
- 7.12.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
- 7.12.5 Praecis Pharmaceuticals Recent Developments
- 7.13 S.G. Biopharm
- 7.13.1 S.G. Biopharm Comapny Information
- 7.13.2 S.G. Biopharm Business Overview
- 7.13.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.13.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
- 7.13.5 S.G. Biopharm Recent Developments
- 7.14 Taj Oncology
- 7.14.1 Taj Oncology Comapny Information
- 7.14.2 Taj Oncology Business Overview
- 7.14.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.14.4 Taj Oncology Oncology Injection Drug Product Portfolio
- 7.14.5 Taj Oncology Recent Developments
- 7.15 Eli Lilly
- 7.15.1 Eli Lilly Comapny Information
- 7.15.2 Eli Lilly Business Overview
- 7.15.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.15.4 Eli Lilly Oncology Injection Drug Product Portfolio
- 7.15.5 Eli Lilly Recent Developments
- 8 North America
- 8.1 North America Oncology Injection Drug Market Size by Type
- 8.1.1 North America Oncology Injection Drug Revenue by Type (2020-2031)
- 8.1.2 North America Oncology Injection Drug Sales by Type (2020-2031)
- 8.1.3 North America Oncology Injection Drug Price by Type (2020-2031)
- 8.2 North America Oncology Injection Drug Market Size by Application
- 8.2.1 North America Oncology Injection Drug Revenue by Application (2020-2031)
- 8.2.2 North America Oncology Injection Drug Sales by Application (2020-2031)
- 8.2.3 North America Oncology Injection Drug Price by Application (2020-2031)
- 8.3 North America Oncology Injection Drug Market Size by Country
- 8.3.1 North America Oncology Injection Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America Oncology Injection Drug Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America Oncology Injection Drug Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 9 Europe
- 9.1 Europe Oncology Injection Drug Market Size by Type
- 9.1.1 Europe Oncology Injection Drug Revenue by Type (2020-2031)
- 9.1.2 Europe Oncology Injection Drug Sales by Type (2020-2031)
- 9.1.3 Europe Oncology Injection Drug Price by Type (2020-2031)
- 9.2 Europe Oncology Injection Drug Market Size by Application
- 9.2.1 Europe Oncology Injection Drug Revenue by Application (2020-2031)
- 9.2.2 Europe Oncology Injection Drug Sales by Application (2020-2031)
- 9.2.3 Europe Oncology Injection Drug Price by Application (2020-2031)
- 9.3 Europe Oncology Injection Drug Market Size by Country
- 9.3.1 Europe Oncology Injection Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe Oncology Injection Drug Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe Oncology Injection Drug Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
- 10 China
- 10.1 China Oncology Injection Drug Market Size by Type
- 10.1.1 China Oncology Injection Drug Revenue by Type (2020-2031)
- 10.1.2 China Oncology Injection Drug Sales by Type (2020-2031)
- 10.1.3 China Oncology Injection Drug Price by Type (2020-2031)
- 10.2 China Oncology Injection Drug Market Size by Application
- 10.2.1 China Oncology Injection Drug Revenue by Application (2020-2031)
- 10.2.2 China Oncology Injection Drug Sales by Application (2020-2031)
- 10.2.3 China Oncology Injection Drug Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Oncology Injection Drug Market Size by Type
- 11.1.1 Asia Oncology Injection Drug Revenue by Type (2020-2031)
- 11.1.2 Asia Oncology Injection Drug Sales by Type (2020-2031)
- 11.1.3 Asia Oncology Injection Drug Price by Type (2020-2031)
- 11.2 Asia Oncology Injection Drug Market Size by Application
- 11.2.1 Asia Oncology Injection Drug Revenue by Application (2020-2031)
- 11.2.2 Asia Oncology Injection Drug Sales by Application (2020-2031)
- 11.2.3 Asia Oncology Injection Drug Price by Application (2020-2031)
- 11.3 Asia Oncology Injection Drug Market Size by Country
- 11.3.1 Asia Oncology Injection Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia Oncology Injection Drug Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia Oncology Injection Drug Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Oncology Injection Drug Market Size by Type
- 12.1.1 SAMEA Oncology Injection Drug Revenue by Type (2020-2031)
- 12.1.2 SAMEA Oncology Injection Drug Sales by Type (2020-2031)
- 12.1.3 SAMEA Oncology Injection Drug Price by Type (2020-2031)
- 12.2 SAMEA Oncology Injection Drug Market Size by Application
- 12.2.1 SAMEA Oncology Injection Drug Revenue by Application (2020-2031)
- 12.2.2 SAMEA Oncology Injection Drug Sales by Application (2020-2031)
- 12.2.3 SAMEA Oncology Injection Drug Price by Application (2020-2031)
- 12.3 SAMEA Oncology Injection Drug Market Size by Country
- 12.3.1 SAMEA Oncology Injection Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA Oncology Injection Drug Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA Oncology Injection Drug Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 Oncology Injection Drug Value Chain Analysis
- 13.1.1 Oncology Injection Drug Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oncology Injection Drug Production Mode & Process
- 13.2 Oncology Injection Drug Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oncology Injection Drug Distributors
- 13.2.3 Oncology Injection Drug Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.